Which treatment option is NOT commonly used for cyclic mastalgia?

Cyclic mastalgia, or cyclical breast pain that often correlates with the menstrual cycle, can result from hormonal fluctuations. The commonly used treatment options aim to alleviate the discomfort by addressing these hormonal influences or providing symptomatic relief.

Bromocriptine is a dopamine agonist that can reduce prolactin levels, and it may be used in some cases to help with breast pain, particularly if elevated prolactin levels are a contributing factor.

Tamoxifen, a selective estrogen receptor modulator, can modulate estrogen activity in breast tissue, and it has been employed in some treatment plans for mastalgia, particularly in cases resistant to other therapies.

NSAIDs (nonsteroidal anti-inflammatory drugs) are frequently used to manage pain and inflammation, making them a common and effective choice for providing symptomatic relief from cyclic mastalgia.

In contrast, antibiotics are not typically indicated for cyclic mastalgia since the condition is not caused by an infection. While they may be useful in cases where an infection or abscess is present, antibiotics do not address the underlying causes of cyclic breast pain that arise from hormonal fluctuations or other non-infectious factors. Therefore, they are not a standard treatment for this specific condition.